GDF-5 Antibodies

Santa Cruz Biotechnology features a diverse variety of GDF-5 monoclonal antibodies for research focused on Growth Differentiation Factor 5 (GDF-5) in various biological processes. GDF-5 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GDF-5 is a member of the transforming growth factor-beta (TGF-β) superfamily and plays a crucial role in cartilage and bone development, as well as in the regulation of cellular differentiation and proliferation. Research has shown GDF-5's significant involvement in osteoarthritis and other musculoskeletal disorders, particularly in tissue repair and regeneration processes. Scientists studying GDF-5 continue to uncover new insights into its role in skeletal development and joint formation. Recent studies have highlighted GDF-5's potential as a therapeutic target for treating various bone and joint conditions. Ongoing research explores GDF-5's function in cellular signaling pathways and its impact on tissue homeostasis. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of GDF-5's role in human health and disease.